Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1994-7-15
pubmed:abstractText
The ovalbumin (OA)-sensitized Brown Norway rat (BN) demonstrates early-response (ER) and late-response (LR) allergic bronchoconstriction. To determine whether these responses could be replicated in vitro, we studied lung explants from 8-wk-old male BN rats (wt: 239 +/- 28 g), of which 19 were sensitized to OA (test) and 16 served as controls. Two weeks after sensitization, the animals' lungs were removed, filled with a 1% (wt/vol) agarose-containing solution at 37 degrees C, and cooled to 4 degrees C. Transverse slices (0.5 to 1.0 mm thick) were cut and cultured overnight. Airways were visualized with an inverted microscope and baseline images were obtained with a video camera. To study the ER, 40 airways from 15 test rats and 29 airways from 10 control rats were challenged with 2 micrograms OA and imaged each minute for 10 min. To study the LR, 40 airways from 12 test rats and 44 airways from 12 control rats were challenged with 2 micrograms OA and imaged each hour for 8 h. The maximal response (MR) for each airway was defined as the percent of airway closure. The ER and LR were both defined as an MR > or = mean + 2 SD of the controls. An ER occurred in 38 of 40 test and 2 of 29 control airways (mean MR: 42 +/- 24% versus 4 +/- 3%, p < 0.001), and was completely blocked by methysergide pretreatment in 13 airways.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1073-449X
pubmed:author
pubmed:issnType
Print
pubmed:volume
149
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1499-505
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8004305-Airway Resistance, pubmed-meshheading:8004305-Animals, pubmed-meshheading:8004305-Asthma, pubmed-meshheading:8004305-Bronchial Provocation Tests, pubmed-meshheading:8004305-Bronchodilator Agents, pubmed-meshheading:8004305-Constriction, Pathologic, pubmed-meshheading:8004305-Disease Models, Animal, pubmed-meshheading:8004305-Drug Hypersensitivity, pubmed-meshheading:8004305-Hypersensitivity, Delayed, pubmed-meshheading:8004305-Hypersensitivity, Immediate, pubmed-meshheading:8004305-Immunoglobulin E, pubmed-meshheading:8004305-Leukotriene D4, pubmed-meshheading:8004305-Male, pubmed-meshheading:8004305-Methysergide, pubmed-meshheading:8004305-Ovalbumin, pubmed-meshheading:8004305-Premedication, pubmed-meshheading:8004305-Propionates, pubmed-meshheading:8004305-Quinolines, pubmed-meshheading:8004305-Rats, pubmed-meshheading:8004305-Serotonin, pubmed-meshheading:8004305-Time Factors
pubmed:year
1994
pubmed:articleTitle
In vitro allergic bronchoconstriction in the brown Norway rat.
pubmed:affiliation
Meakins-Christie Laboratories, Royal Victoria Hospital, Montreal, Quebec, Canada.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't